Gladis Zamparo will lead the commercial testing organization in its next phase of growth and innovation

November 16, 2020 — Bionique Testing Laboratories, Inc. is thrilled to announce that it has selected Gladis Zamparo as its next CEO effective November 16, 2020. Zamparo has spent two decades in global organizations driving change through innovative solutions, operational excellence and financial rigor.

“I am excited to work with Bionique’s terrific team to build on its impressive track record and lead the organization through its next phase of innovation and growth. This will include continuing to support the method development, validation and implementation of novel rapid testing platforms
that address our clients evolving requirements and investments in new services to meet the critical needs of the biopharmaceutical and cell therapy markets growth,” says Zamparo. “With greater scale and its unparalleled scientific expertise, Bionique has an opportunity to shape how the
mycoplasma testing sector evolves, in a way that generates measurable impact to our clients and partners. I look forward to collaborating with Bionique’s staff and board to elevate the organization’s profile and take its capacity for impact and scale to the next level.”

Gladis joined Bionique in 2016 as CFO and has over twenty years of experience in business and financial management across small businesses and corporations. Prior to Bionique, Gladis was at J.P. Morgan for six years, where she held multiple roles in Finance and Business Management for
the Investor Services Division. Earlier in her career, she was the first woman to serve as the Executive Director for the Beijing based China‐Italy Chamber of Commerce. Gladis holds an MBA from NYU Stern School of Business.

“Jill Mariano MD, Bionique’s executive chair and outgoing CEO stated: “In her years of serving Bionique, Gladis brings a rare combination of fierce commitment to the clients we serve, deep knowledge of finance, investing, and profound leadership capabilities. This is Bionique’s moment,
and Gladis is the right person to seize it.”

Company Overview

Bionique Testing Laboratories, Inc. (Bionique) has been a leading global provider of mycoplasma testing services for the life science industry for over 30 years. Bionique offers the full breadth of services from the Lot & Final Drug Product release testing per regulatory guidelines to a GMP
compliant Real-Time PCR assay to support clients’ needs from concept to clinical trials and commercialization for biopharmaceutical and cell & gene therapy products. Bionique’s experience and expertise extends to development and validation of rapid microbiological methods to generate
real time results. Additional services such as regulatory and compliance consultancy add to Bionique’s unique position in this niche analytical testing space. Located in Saranac Lake, NY, Bionique is a FDA registered and GMP compliant contract testing facility. Bionique aims at offering unsurpassed quality mycoplasma testing services to meet the custom scientific and regulatory needs of each client and partner.